These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 773605)

  • 41. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
    Ergova R; K'oleian E; Kharalambieva Ia; Mitov I; Docheva Iu
    Vutr Boles; 2000; 32(1):13-7. PubMed ID: 11195191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo microbiological evaluation of Cephapirin, a new antibiotic.
    Renzini G; Ravagnan G; Oliva B
    Chemotherapy; 1975; 21(5):289-96. PubMed ID: 1098870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Talampicillin hydrochloride: Comparison with amoxicillin and ampicillin in the antibacterial activity and pharmacokinetics (author's transl)].
    Tachibana A; Ohtani K; Komiya M; Naito S; Shimizu C; Yano K
    Jpn J Antibiot; 1978 Mar; 31(3):166-76. PubMed ID: 246947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-dose therapy for cystitis in women. A comparison of trimethoprim-sulfamethoxazole, amoxicillin, and cyclacillin.
    Hooton TM; Running K; Stamm WE
    JAMA; 1985 Jan; 253(3):387-90. PubMed ID: 3871233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Penicillins. A current review of their clinical pharmacology and therapeutic use.
    Nathwani D; Wood MJ
    Drugs; 1993 Jun; 45(6):866-894. PubMed ID: 7691496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antimicrobial activity of a dihydroampicillin and a dihydrocephalexin.
    Hashem AI; Shaban ME; Abdel-Aziz R; Abdel-Nasser G
    Arch Pharm (Weinheim); 1998 Sep; 331(9):294-6. PubMed ID: 9793485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial activity of the combination ampicillin-kanamycin against gram-negative bacteria.
    Klastersky J; Daneau D; Van Moer N
    Pathol Biol (Paris); 1972 May; 20(9):443-8. PubMed ID: 4625078
    [No Abstract]   [Full Text] [Related]  

  • 48. Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.
    Bach VT; Thadepalli H
    Chemotherapy; 1980; 26(5):344-53. PubMed ID: 6446448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of the antibacterial activity in vitro of a combination of penicillin and other antibiotics on 127 strains isolated in an Oncological Institute].
    Buogo A; Zanuso G; Cattaneo P
    Minerva Med; 1975 Aug; 66(54):2690-6. PubMed ID: 1153119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative evaluation of cyclacillin and ampicillin in urinary tract infections. A double-blind study.
    Henri A; Klastersky J
    Chemotherapy; 1974; 20(2):102-12. PubMed ID: 4367636
    [No Abstract]   [Full Text] [Related]  

  • 52. beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection.
    Brauner A; Dornbusch K; Hallander HO
    Scand J Infect Dis Suppl; 1978; (13):67-72. PubMed ID: 356181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial activity of cyclacillin against Escherichia coli in vivo and in vitro.
    Friedman H; Warren GH
    Experientia; 1971 Oct; 27(10):1241-3. PubMed ID: 4331424
    [No Abstract]   [Full Text] [Related]  

  • 54. Microbiological properties of sulbactam combined with ampicillin.
    Barba D; Galante D; Esposito S; Ruffilli MP
    Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclacillin: a clinical and in vitro profile.
    Gonzaga AJ; Antonio-Velmonte M; Tupasi TE
    J Infect Dis; 1974 May; 129(5):545-51. PubMed ID: 4362998
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparison of the pharmacokinetics of bacampicillin, ampicillin, amoxicillin, and cyclacillin: oral administration in infants and children.
    McCracken GM
    Bull N Y Acad Med; 1983 Jun; 59(5):468-76. PubMed ID: 6576831
    [No Abstract]   [Full Text] [Related]  

  • 58. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
    Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antibacterial activity in vitro and in vivo in animals of a combination of 2 semisynthetic penicillins: dicloxacillin and ethacillin].
    Varone GL; Catalano G; Abbate GF; Fici F
    G Mal Infett Parassit; 1972 Apr; 24(4):231-42. PubMed ID: 5050303
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro antibacterial activity of cefixime.
    Lin SR; Peng CF
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Oct; 4(10):586-91. PubMed ID: 3230604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.